AN2 Therapeutics Reports Phase 3 Data from EBO-301 Study
01 May 2025 //
BUSINESSWIRE
Incheon National University Scientists Review Progress in Anticancer Compounds
26 Jan 2022 //
PRNEWSWIRE
01 May 2025 //
BUSINESSWIRE
26 Jan 2022 //
PRNEWSWIRE